MedDataX Logo

Intervention on Non-prescription Antibiotic Use Among the Public

NCT06317415 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1550

Last updated 2024-03-20

No results posted yet for this study

Summary

The purpose of this study is to test the effectiveness of health education int led by community health workers for non-prescription antibiotic use among the public. In this two arm cluster randomised trial, In this two-arm cluster randomized controlled trial, 22 communities were randomly allocated in a 1:1 ratio to intervention and control groups. In the intervention group, family doctors will conduct WeChat-based health education on responsible use of antibiotic for the participants. In the control group, only routine public health education will be provided without any involvement in antibiotic use. The primary outcome is the incidence of antibiotic use without prescription in the past month.

Conditions

  • Non-Prescription Drug Misuse
  • Antibiotic Use

Interventions

BEHAVIORAL

WeChat-based health education on antibiotic use

Health education based on the WeChat platform includes popular science articles on WeChat public Platform and health education videos.

BEHAVIORAL

Regular public health education

Health education information on the prevention and control of common chronic diseases

Sponsors & Collaborators

  • Fuyong People's Hospital, Bao 'an District, Shenzhen City, Guangdong

    collaborator UNKNOWN

  • Huazhong University of Science and Technology

    lead OTHER

Principal Investigators

  • Xiaoxv Yin · Huazhong University of Science and Technology

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2023-12-31
Completion
2024-03-01

Countries

  • China

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06317415 on ClinicalTrials.gov